📚 Lecture Overview
This lecture covers Acute Liver Failure (ALF) and Hepatic Encephalopathy (HE), defining their clinical presentations, etiologies, and diagnostic frameworks. Mastering these topics is vital because ALF is a rapidly progressive, life-threatening emergency requiring prompt intensive care and potential liver transplantation, while HE represents a major neuropsychiatric complication of liver insufficiency that demands rigorous identification of precipitating factors.
🎯 Key Concepts & Definitions
- Acute Liver Failure (ALF): A rare, devastating syndrome of acute deterioration of liver function—marked by jaundice and coagulopathy (INR >1.5)—occurring without underlying chronic liver disease and developing hepatic encephalopathy up to 12 weeks post-jaundice.
- Severe Acute Liver Injury (ALI): Liver damage (serum aminotransferases 2-3x ULN) and impaired liver function with jaundice and coagulopathy, strictly lacking hepatic encephalopathy.
- Hepatic Encephalopathy (HE): A reversible, broad spectrum of neuropsychiatric abnormalities ranging from subclinical alterations to deep coma, caused by liver insufficiency and/or portosystemic shunting (PSS).
- Overt Hepatic Encephalopathy (OHE): Clinically apparent HE diagnosed using clinical criteria, the West Haven Classification, and the Glasgow Coma Scale.
- Minimal/Covert Hepatic Encephalopathy (MHE/CHE): Subclinical brain dysfunction detectable only through specialized psychometric or neurophysiological tests (e.g., EncephalApp Stroop Test).
- High-Volume Plasma Exchange (HVP): Exchange of 8-12% or 15% of ideal body weight with fresh frozen plasma for 3 days; proven superior to standard medical therapy in ALF.
📖 Main Content
Acute Liver Failure: Definition, Sub-classification & Causes
- ALF is characterized by severe metabolic derangements, neurologic complications, and multiorgan failure.
- Sub-classified by the interval from jaundice to HE:
- Hyperacute: 0 to 7 days
- Acute: >7 days to 28 days
- Subacute: >28 days up to 24 weeks
- Etiologies:
- Viral Hepatitis: Hepatitis B (most common), A, and E (less frequent: CMV, HSV, VZV, Dengue).
- Drugs/Toxins: Paracetamol overdose (most frequent cause of severe ALI/ALF), anti-tuberculous drugs, chemotherapy, statins, NSAIDs, Amanita phalloides.
- Vascular & Pregnancy: Budd-Chiari syndrome, hypoxic hepatitis, HELLP syndrome, acute fatty liver of pregnancy.
- Other: Wilson disease, autoimmune hepatitis, malignancies.
Assessment, Organ Support & Management of ALF
- Immediate Measures: Exclude pre-existing cirrhosis (except acute presentation of Wilson disease, autoimmune hepatitis, or Budd-Chiari), determine etiology, screen for HE, and evaluate for emergency liver transplantation (LTx).
- Cardiovascular: Systemic vasodilation leading to reduced effective central blood volume.
- Metabolic & Renal: Frequent hypoglycaemia, hyponatraemia, acidosis, and electrolyte imbalances. Acute Kidney Injury (AKI) affects 40-80% of ALF referrals.
- Coagulation: Rapid changes in PT/INR are prognostic; thrombocytopenia and decreased pro-/anti-coagulant proteins are common. Prophylactic correction of coagulation/platelets is NOT necessary and increases thrombosis or transfusion-related lung injury risks.
- Infection & Sepsis: High risk of sepsis mediated by systemic inflammatory response syndrome (SIRS). Early empirical antibiotics are warranted if hemodynamic deterioration occurs.
- Neuromangement of HE in ALF:
- Quiet environment, head of bed >30° in a neutral position.
- Intubate and mechanically ventilate on progression to Grade 3 or 4 coma.
Hepatic Encephalopathy: Pathogenesis, Classification & Diagnosis
- Prevalence: Affects 30-40% of patients with cirrhosis overall; 16-21% in decompensated cirrhosis; up to 50% post-TIPS.
- Precipitating Factors: Controlling precipitants is the cornerstone of management because ~90% of patients improve with precipitating factor correction alone. Common triggers include infection, GI bleeding, constipation, electrolyte imbalances, and sedatives. Large spontaneous portal-systemic shunts (e.g., splenorenal shunts) can cause recurrent/persistent HE.
- Diagnostic Tests:
- Blood Ammonia: High blood ammonia alone adds no diagnostic, staging, or prognostic value in chronic liver disease. Normal levels call for diagnostic re-evaluation.
- Psychometric Tests: Psychometric Hepatic Encephalopathy Score (PHES), Number Connection Tests (NCT-A and NCT-B).
- Stroop Smartphone App (EncephalApp): A validated, simple, free tool measuring psychomotor speed and cognitive flexibility with a cut-off time of >190 seconds identifying covert HE accurately.
Treatment of Overt Hepatic Encephalopathy
- Four-Pronged Approach:
1. Airway protection and ICU care.
2. Search for and treat alternative causes of altered mental status.
3. Identify and correct precipitating factors.
4. Commence empirical HE treatment. - Nonabsorbable Disaccharides (Lactulose / Lactitol): 1st line therapy. Acts as a laxative, lowers colonic pH, converts absorbable $NH_3$ into non-absorbable $NH_4^+$, and promotes non-urease-producing bacteria.
- Antibiotics:
- Rifaximin: Minimally absorbed, broad-spectrum antibiotic (550 mg/12hr) with high barrier to resistance; usually combined with lactulose for superior ammonia-lowering and lower recurrence rates.
- Neomycin: Older agent (3-4g/day); carries significant risks of nephrotoxicity and ototoxicity.
- Other Agents:
- Oral BCAAs: Improve episodic HE manifestations.
- L-ornithine L-aspartate (LOLA): IV form improves psychometric testing and postprandial venous ammonia.
- Secondary Prophylaxis: Mandatory after the first overt HE episode, typically utilizing continuous lactulose combined with rifaximin to prevent breakthrough episodes and hospitalizations.
- Liver Transplantation: Ultimate treatment for recurrent, treatment-resistant OHE in cirrhosis or severe ALF.
📊 Visual Learning
flowchart TD
A[Acute Liver Injury] --> B{Has Encephalopathy?}
B -->|No| C[Severe Acute Liver Injury ALI]
B -->|Yes| D[Acute Liver Failure ALF]
D --> E[Check Time to HE]
E -->|0 to 7 days| F[Hyperacute ALF]
E -->|7 to 28 days| G[Acute ALF]
E -->|28 days to 24 weeks| H[Subacute ALF]
mindmap
root("Hepatic Encephalopathy")
"Pathogenesis"
"Liver Insufficiency"
"Portosystemic Shunts PSS"
"Multifactorial Toxins"
"Diagnosis"
"Clinical West Haven"
"EncephalApp Stroop Test"
"Exclusion of Other Causes"
"Treatment"
"Correct Precipitating Factors"
"Lactulose First Line"
"Rifaximin Combination"
"Liver Transplantation"
flowchart LR
A[Identify Precipitant] --> B[Correct Trigger]
B --> C[Start Lactulose]
C --> D[Add Rifaximin]
D --> E[Evaluate for LTx if Refractory]
💡 Important Points to Remember
- ALF Definition Check: ALF requires acute liver injury WITHOUT underlying chronic liver disease plus the development of coagulopathy (INR >1.5) and hepatic encephalopathy within 12 weeks of jaundice.
- Exceptions to Chronic Rule: Acute presentations of autoimmune hepatitis, Wilson disease, and Budd-Chiari syndrome are classified as ALF if HE develops.
- The 90% Rule: Approximately 90% of overt HE episodes can be resolved strictly by identifying and correcting the precipitating factor.
- Ammonia Reality: High blood ammonia alone has no diagnostic or prognostic value in chronic liver disease. Normal ammonia should trigger a diagnostic re-evaluation.
- Coagulation Trap: Abnormal PT/INR in ALF does not indicate a high bleeding risk; prophylactic correction with plasma or platelets is contraindicated.
- Lactulose Mechanism: Lactulose lowers intestinal pH, trapping ammonia as non-absorbable ammonium ($NH_4^+$) and acting as a laxative.
- Rifaximin Rule: Rifaximin monotherapy is unproven; it is typically combined with lactulose for secondary prophylaxis.
- Neomycin Toxicity: Neomycin is rarely used today due to severe risks of nephrotoxicity and ototoxicity.
- MELD and HE: HE does not reliably correlate with MELD score, often disadvantaging HE patients in organ allocation despite severe survival impact.
- High-Volume Plasma Exchange (HVP): Proven in RCTs to improve transplant-free survival in ALF by exchanging 8-15% of ideal body weight with fresh frozen plasma.
⚠️ Common Exam Questions
- MCQ Trap on ALF vs. ALI: Examiners will describe a patient with elevated transaminases, jaundice, and an INR of 2.0, but no mental status changes. Students often incorrectly pick "Acute Liver Failure"—the correct diagnosis is Severe Acute Liver Injury (ALI) because hepatic encephalopathy is absent.
- MCQ Trap on Ammonia: A question might state that a high blood ammonia level confirms the grade and prognosis of HE in a cirrhotic patient. False! Ammonia levels alone do not correlate with staging or prognosis in chronic liver disease.
- Short Answer / Management: "A patient with cirrhosis develops sudden overt hepatic encephalopathy. What is the single most important immediate management step?" Identify and correct the precipitating factor (which accounts for ~90% of reversals).
- Coagulation Management Trick: An examiner asks whether fresh frozen plasma should be given prophylactically to correct an INR of 2.5 in an ALF patient prior to central line placement. No! Coagulation is rebalanced; prophylactic correction is unhelpful and increases transfusion-related lung injury risks.
📝 Quick Review Checklist
I can define Acute Liver Failure and list its temporal sub-classifications
I understand the core etiologies of ALF (viral, drugs, vascular)
I can differentiate between ALI and ALF based on the presence of HE
I know the key pathognomonic features and primary causes of death in ALF (cerebral edema, SIRS, sepsis)
I understand why prophylactic correction of coagulation in ALF is contraindicated
I can classify Hepatic Encephalopathy (OHE, MHE/CHE)
I know the common precipitating factors of HE and their management
I can explain the mechanism of action of lactulose and rifaximin
I recognize that blood ammonia levels lack standalone staging/diagnostic value in chronic liver disease
I know the indications for secondary prophylaxis and emergency liver transplantation